TABLE 1 WORLD IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2 WORLD IMMUNODIAGNOSTICS REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 3 WORLD IMMUNODIAGNOSTICS INSTRUMENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4 WORLD IMMUNODIAGNOTICS SOFTWARE & SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 5 WORLD IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 6 WORLD IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 7 WORLD ELISA MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8 WORLD CLIA MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9 WORLD RIA MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10 WORLD FIA MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 WORLD RAPID TEST MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12 WORLD OTHER TECHNOLOGIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 WORLD IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 14 WORLD IMMUNODIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15 WORLD IMMUNODIAGNOSTICS MARKET FOR ONCOLOGY AND ENDOCRINOLOGY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 WORLD IMMUNODIAGNOSTICS MARKET FOR BONE AND MINERAL DISEASES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 17 WORLD IMMUNODIAGNOSTICS MARKET FOR AUTOIMMUNITY DISEASES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18 WORLD IMMUNODIAGNOSTICS MARKET FOR CARDIAC BIOMARKERS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 19 WORLD IMMUNODIAGNOSTICS MARKET FOR DRUG MONITORING, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 WORLD IMMUNODIAGNOSTICS MARKET FOR OTHER APPLICTIONS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 WORLD UMMUNODIAGNOSTICS MARKET, BY END USER, 20142022, ($MILLION)
TABLE 22 WORLD IMMUNODIAGNOSTICS MARKET FOR CLINICAL LABORATORIES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23 WORLD IMMUNODIAGNOSTICS MARKET FOR HOSPITALS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 24 WORLD IMMUNODIAGNOSTICS MARKET FOR ACADEMIC AND RESEARCH CENTERS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 WORLD IMMUNODIAGNOSTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26 WORLD IMMUNODIAGNOSTICS MARKET FOR OTHER END USER, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 27 WORLD IMMUNODIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 28 NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 29 NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 30 NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 31 NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 32 NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 33 U.S.: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 34 CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 35 MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 36 EUROPE IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 37 EUROPE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 38 EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 39 EUROPE IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 40 EUROPE IMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 41 GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 42 FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 43 U.K.: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 44 REST OF EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 45 ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 46 ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 47 ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 48 ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 49 ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 50 INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 51 CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 52 JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 53 AUSTRALIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 54 LAMEA IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 55 LAMEA IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 56 LAMEA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 57 LAMEA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 58 LAMEA IMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 59 LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 60 MIDDLE EAST: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 61 AFRICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 62 ABBOTT: COMPANY SNAPSHOT
TABLE 63 ABBOTT: OPERATING SEGMENTS
TABLE 64 SIEMENS-COMPANY SNAPSHOT
TABLE 65 SIEMENS-OPERATING SEGMENTS
TABLE 66 IDS-COMPANY SNAPSHOT
TABLE 67 IDS: OPERATING SEGMENTS
TABLE 68 DIASORIN-COMPANY SNAPSHOT
TABLE 69 DIASORIN OPERATING SEGEMENTS
TABLE 70 JOHNSON & JOHNSON COMPANY SNAPSHOT
TABLE 71 JOHNSON & JOHNSON OPERATING SEGEMENTS
TABLE 72 ROCHE - COMPANY SNAPSHOT
TABLE 73 ROCHE - OPERATING SEGMENTS
TABLE 74 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 75 SYSMEX CORPORATION - OPERATING SEGMENTS
TABLE 76 DANAHER - COMPANY SNAPSHOT
TABLE 77 DANAHER - OPERATING SEGMENTS
TABLE 78 THERMO FISHER -COMPANY SNAPSHOT
TABLE 79 THERMO FISHER - OPERATING SEGMENTS
TABLE 80 BIO-RAD-COMPANY SNAPSHOT
TABLE 81 BIO-RAD : OPERATING SEGMENTS
LIST OF FIGURE
FIG. 1 TOP INVESTMENT POCKETS IN IMMUNODIAGOSTICS MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20142016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 4 TOP WINNING STRATEGIES: NATURE AND COMPANY
FIG. 5 PORTERS FIVE FORCES ANALYSIS
FIG. 6 VALUE CHAIN ANALYSIS FOR IMMUNODIAGNOSTICS MARKET
FIG. 7 MARKET SHARE ANALYSIS: IMMUNODIAGNOSTICS MARKET, 2015
FIG. 8 RESTRAINTS AND DRIVERS: WORLD IMMUNODIAGNOSTICS MARKET
FIG. 9 GLOBAL INCIDENCE OF DISEASES
FIG. 10 IMMUNODIAGNOSTICS TECHNOLOGY
FIG. 11 GENERAL CLASSIFICATION OF INFECTIOUS DISEASES
FIG. 12 ESTIMATED NUMBER OF CANCER DEATHS BY SEX, U.S., 2016
FIG. 13 ESTIMATED NUMBER OF HIV RELATED DEATHS, SOUTH AFRICA , 2016
FIG. 14 ABBOTT: NET SALES, 20132015 ($MILLION)
FIG. 15 ABBOTT: REVENUE BY BUSINESS SEGMENTS, 2015 (%)
FIG. 16 ABBOTT: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 17 ABBOTT: STRATEGY SHARE, 2014-2016 (%)
FIG. 18 SEIMENS: REVENUE, 2013-2015, ($MILLION)
FIG. 19 SEIMENS: REVENUE BY SEGMENT, 2015 (%)
FIG. 20 SEIMENS: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 21 IDS: REVENUE, 2013-2016, ($MILLION)
FIG. 22 IDS: REVENUE, BY BUSINESS SEGMENTS, 2016 (%)
FIG. 23 IDS: REVENUE, BY GEOGRAPHY, 2016, (%)
FIG. 24 DIASORIN: REVENUE, 2013-2015, ($MILLION)
FIG. 25 DIASORIN: REVENUE, BY BUSINESS SEGMENTS, 2015 (%)
FIG. 26 DIASORIN: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 27 DIASORIN: STRATEGY SHARE, 2014-2016 (%)
FIG. 28 JOHNSON & JOHNSON: REVENUE, 2013-2015, ($MILLION)
FIG. 29 JOHNSON & JOHSNON : REVENUES BY SEGMENTS (2015)
FIG. 30 JOHNSON & JOHSNON : REVENUES BY GEOGRAPHY (2015)
FIG. 31 JOHNSON & JOHSNON: STRATEGY SHARE, 2014-2016 (%)
FIG. 32 ROCHE: NET SALES, 20132015 ($MILLION)
FIG. 33 ROCHE: REVENUEBY BUSINESS SEGMENTS, 2015 (%)
FIG. 34 ROCHE: REVENUEBY GEOGRAPHY, 2015 (%)
FIG. 35 SYSMEX CORPORATION: REVENUE, 2013-2015, ($MILLION)
FIG. 36 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT (2015)
FIG. 37 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY (2015)
FIG. 38 SYSMEX CORPORATION: STRATEGY SHARE, 2014-2016 (%)
FIG. 39 DANAHER: NET SALES, 20132015 ($MILLION)
FIG. 40 DANAHER: REVENUEBY BUSINESS SEGMENTS, 2015 (%)
FIG. 41 DANAHER: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 42 THERMO FISHER : REVENUE BUSINESS SEGMENTS, 2015 (%)
FIG. 43 THERMO FISHER: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 44 THERMO FISHER: REVENUE, 2013- 2015, ($MILLION)
FIG. 45 BIO-RAD : REVENUE, 20132015, ($MILLION)
FIG. 46 BIO-RAD: REVENUE, BY BUSINESS SEGMENTS, 2015 (%)
FIG. 47 BIO-RAD: REVENUE, BY GEOGRAPHY, 2015, (%)
FIG. 48 BIO-RAD: STRATEGY SHARE, 2014-2016 (%)
